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Objective: To assess the toxic potential of Dissotis rotundifolia (D. rotundifolia) whole
plant extract in Spraque–Dawley rats within a 2-week period of administration.
Methods: Methanolic extract of D. rotundifolia was administered orally once daily at
dose levels of 0, 100, 300 and 1000 mg/kg body weight for 14 days. Toxicity was
assessed using mortality, clinical signs, body and organ weights, hematological indices,
serum chemistry parameters and histopathological analyses.
Results: There were no treatment-related mortalities or differences in clinical signs,
hematology and serum biochemistry. This was conﬁrmed by micrographs obtained from
histopathological analysis.
Conclusions: The results obtained from the sub-acute toxicological assessment of
D. rotundifolia extract suggest that the extract is non-toxic at doses up to 1000 mg/kg/day
administered for a period of 14 days.1. Introduction
Medicinal plants have played a major role in the development
of modern orthodox medicines and continue to be widely used in
their original form [1]. Published data indicate that about 80% of
the world's population depend on plant medicine for healthcare
delivery and about 70%–95% of developing countries rely onplant medicine for primary healthcare [2]. Implicitly, the practice
of herbal medicine is gradually becoming the mainstream
throughout the world. This may be due in part to the recognition
of the value of traditional medical systems and the identiﬁcation
of medicinal plants from indigenous pharmacopeias that have
been shown to have signiﬁcant pharmacotherapeutic effect,
either in their natural state or as a source of new pharmaceuticals.
In the Ghanaian setting about 80% of the populace rely on
plants for healthcare [2]. This is an indication that plant medicine
continues to play a key role in maintaining healthcare. In Ghana,
plants have been used as food and treatments for several
ailments for decades with little or no scientiﬁc data on their
safety. The practice has rested largely on clinical experience.
Phytomedicines are widely patronized and perceived to be of
low risk in comparison to synthetic drugs [3], because they are
natural though they are not completely free of toxic or other
adverse effects [4]. The popularity of plant medicines coupled
to scarcity of evidence-based data on their safety has raised
serious concerns regarding their therapeutic value. The evalua-
tion of toxic effects of plant medicines in rodents and otherarticle under the CC BY-NC-ND license (http://
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of plant preparations as cosmetics and medicine demands that
they are assessed for their toxicity proﬁle.
Dissotis rotundifolia (D. rotundifolia) is a member of the
family Melastomataceae and geographically native to some parts
of Africa including Western and Eastern Africa [5,6]. The plant is
among the most widely used medicinal plants in tropical Africa,
and has been reported to have various ethno-medicinal uses.
Considering the phytoconstituents of the whole plant [7] and its
reported pharmacological effects on worm infection, diarrhea,
cough, dysentery, peptic ulcer and other diseases [8–13], proof of
toxicological assessment of the whole plant extract is necessary
in order to assure consumers of its safety. Thus, this study was
designed to assess the potential toxicity of D. rotundifolia
extract (DRE) in male and female Sprague–Dawley (SD) rats.
2. Materials and methods
2.1. Collection of plant material and preparation of
extract
The D. rotundifolia whole plant was collected from the envi-
ronment around the Kakum National Park, Cape Coast, Ghana in
January 2012 and authenticated by the Curator at theHerbariumof
the Department of Environmental Science, School of Biological
Sciences, University of Cape Coast. A voucher specimen (No.
107346) was prepared and deposited at the herbarium. The whole
plant was washed thoroughly, shade-dried for three weeks, oven-
dried at 40 C for 3 h then pulverized into powder.
The method of extraction described by Rath et al. [7] involving
the use of dichloromethane and 70% methanol was employed in
the preparation of the crude whole plant extract. One hundred and
ﬁfty gram of powder was transferred into a 2 L ﬂask and 1.5 L of
dichloromethane was added in a fume chamber. The ﬂask was
tightly corked with a cotton wool plug, which was covered with
an aluminium foil and placed on an orbital shaker (IKA HS/
KS260 basic orbital shaker-Werke-GmbH & Co. KG Germany)
at a speed of 200 r/min for 48 h. The resulting mixture was then
ﬁltered into a 2 L ﬂat bottom ﬂask using a Whatman No.1 ﬁlter
paper. The residuewas dried at 40 Con awater bath and the ﬁltrate
was discarded appropriately. A volume of 1.5 L of 70% methanol
was added to the dried residue corked with a cotton wool plug and
placed on an orbital shaker at 200 r/min for 48 h. The resulting
mixturewas again ﬁltered using aWhatmanNo.1 paper. The ﬁltrate
was subsequently concentrated using a rotary evaporator (BU¨CHI
rotavapor R-200, Germany) and later dried at 40 C in an oven to
obtain a brown coffee-colored extract and this was labeled as DRE.
This extraction process was repeated on 2000 g of powdered plant
sample. The crude DRE was stored at −20 C until ready for use.
2.2. Experimental animals and maintenance
Male and female SD rats (200–270 g) were obtained from the
Centre for Plant Medicine Research. The experimental protocol
was approved by the Faculty of Pharmacy and Pharmaceutical
Sciences Animal Experimentation Ethics Committee of the
Kwame Nkrumah University of Science and Technology,
Kumasi, Ghana and the experiments were conducted according
to the guidelines on the use and care of experimental animals as
provided by the Organization for Economic Cooperation and
Development [14]. Animals were fed with commercial rat feed
supplied by Ghana Agro Food Company Tema, Ghana andwater ad libitum. They were maintained at a 12 h light/dark
cycle at (25 ± 2) C. All animals were acclimatized for two
weeks before start of any experiment.
2.3. Treatment and toxicity assessment
The median lethal dose (LD50) values of the extracts were
determined according to the method of Finney [15]. DRE at a
maximum dose level of 5000 mg/kg (orally) was used for
acute oral toxicity study. A total of 30 males and 30 females
SD rats were selected and divided into 6 groups of 10 rats
each (5 males and 5 females) per group. Group 1 served as
control and received distilled water only. Groups 2–6 were
treated with extracts at different doses (10, 100, 500, 2500
and 5000 mg/kg body weight). Each rat in a group received
the same extract dose administered as a single oral dose.
Mortality, if any, was determined within 24 h and observation
continued for a 2-week period. In addition, observations
including changes in colors of the skin, fur, eyes, salivation,
lacrimation, perspiration, piloerection, urinary incontinence,
defecation, drowsiness, tremors, and convulsions were made.
In the 14-day sub-acute oral toxicity assessment study, animals
were divided into four groups of male rats and four groups of
female rats. Each group comprised either 4 males or 4 females.
Group 1 of each sex received 2mL of distilled water and served as
control. Groups 2, 3 and 4, received daily oral doses of 100, 300
and 1000 mg/kg, respectively at a volume of 2 mL. The extract
was administered daily for a period of 14 days at the same time,
9:00 am and observed at least twice daily for morbidity and for
physical signs of toxicity. Body and organ wet weights,
biochemical and hematological indices were assessed in all ani-
mals at baseline and at the end of treatment. Animals were fasted
overnight prior to necropsy and blood collection. Blood samples
from each animal were collected into two tubes, one containing
ethylenediamine-tetraacetate and the other gel separator. At
termination, organs such as liver, kidney, spleen, and stomach
were excised, weighed and used for histopathological studies.2.3.1. Measurement of hematological indices
Blood samples were earlier collected into ethylenediamine-
tetracetate-2K tubes and analyzed for red blood cell (RBC),
hemoglobin (HGB), pack cell volume or hematocrit (HCT),
mean corpuscular volume, mean corpuscular, mean corpuscular
HGB concentration, red cell distribution width-standard devia-
tion, platelets, mean platelet volume, platelet distribution width,
white blood cell (WBC) counts, neutrophils, lymphocytes using
a Sysmex-KX-2IN hematology auto-analyser.
2.3.2. Determination of clinical biochemistry indices
Blood samples collected earlier into gel separator tubes were
processed for plasma by centrifuging for 5 min at 3000 r/min to
ensure separation of plasma. Plasma samples were stored
at −20 C until ready for use. The plasma was analyzed for
levels of total protein (TP), albumin (ALB), globulin (GLB),
total bilirubin (TB), indirect bilirubin (IDB), direct bilirubin
(DB), alkaline phosphatase (ALP), alanine aminotransferase
(ALT), aspartate aminotransferases (AST), total cholesterol
(TC), triglycerides (TG), low-density lipoprotein cholesterol
(LDL-C), high-density lipoprotein cholesterol (HDL-C), very
low-density lipoprotein cholesterol (VLDL-C), urea, creatinine
(CRE) and lactate dehydrogenase (LDH) using an automated
Table 2
Body weights in rats orally treated with DRE during sub-acute studies.
Treatment Body weight (g) P value
Initial Final
Control 238.12 ± 12.62 256.00 ± 13.70 0.000
100 mg/kg 252.12 ± 13.11 239.00 ± 8.93 0.267
300 mg/kg 237.50 ± 6.25 234.12 ± 8.27 0.664
1000 mg/kg 235.00 ± 8.67 251.89 ± 15.37 0.088
Values are mean ± SEM, (n = 8); data analyzed using paired t-test.
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analyzer (WS-ATAC8000)]. The plasma was also analyzed for
levels of K and Na+ using Selectra Junior autoanalyzer.
2.3.3. Histopathology analysis
Immediately, after the collection of blood samples, animals
were opened up and various body organs were harvested. These
internal organs which included heart, liver, spleen, kidneys and
stomach tissues were cleared of fat and connective tissues,
blotted with clean wipes, examined macroscopically and indi-
vidually weighed to obtain the organ wet weights. All tissues
were preserved in a 10% neutral buffered formalin solution.
For histopathological examinations, excised internal organ
tissues of rats were cleaned in physiological saline,ﬁxed inBouin's
ﬂuid, dehydrated in increasing concentrations of ethanol and
embedded in parafﬁn wax. Thereafter, sections of tissues were cut
at 5 mmwith a rotarymicrotome andmounted on clean glass slides.
Sections were stained with haematoxylin and eosin (H & E) as
described by Bancroft and Gamble [16]. The stained tissues were
observed through an Olympus microscope and photographed by
charecouple device camera at total magniﬁcations 100×.
2.4. Data analysis
Data collected were analyzed using GraphPad Prism, win-
dows version 4.02 (GraphPad Software, San Diego, CA, USA).
Descriptive and inferential statistics including means, t-test and
ANOVA were employed in analysis of data except for histo-
pathology results where micrographs were shown. A probability
value of less than 5% was used to determine signiﬁcant differ-
ences. Bonferroni post-hoc multiple test were performed where a
signiﬁcant difference was recorded for ANOVA.
3. Results
3.1. LD50 and acute toxicity studies
No mortality was recorded at all dose levels (10–5000 mg/kg
body weight) of DRE over the 24-h period. Furthermore,
compared to the control group, the animals treated with all dose
levels of DRE did not show signs of aggressiveness, vomiting,
respiratory distress, salivation, sedation and diarrhoea. Daily
observation over the 14 days post-treatment did not reveal evi-
dence of latent DRE-related toxicities.
3.2. Effect of DRE on organ and body weight
The results presented in Table 1 showed that liver, heart,
kidney, lungs, stomach and spleen from DRE-treated animals
did not show signiﬁcant changes (P > 0.05) compared to organsTable 1
Organ weights in rats orally treated with DRE during sub-acute studies (g).
Parameters Liver Kidney Heart
Control 1.620 ± 0.120 1.300 ± 0.070 0.790 ± 0
100 mg/kg 1.510 ± 0.040 1.250 ± 0.080 0.780 ± 0
300 mg/kg 1.470 ± 0.110 1.210 ± 0.040 0.750 ± 0
1000 mg/kg 1.450 ± 0.050 1.280 ± 0.050 0.730 ± 0
Values are mean ± SEM, (n = 8) (14 days).from vehicle-treated animals. There were no changes in the body
weight in all extract-treated groups with the exception of control
group after 14 days of treatment (Table 2).
3.3. Effect of DRE on hematological parameters
The results indicated that most of the hematological param-
eters measured remained unchanged within the two-week
experimental period when compared to control groups. The
signiﬁcant changes observed in WBC counts were not dose-
related (P > 0.05) (Table 3).
3.4. Effect of DRE on serum biochemical parameters
The data for the biochemical parameters were presented in
Table 4. The effect of the extract on serum biochemical pa-
rameters after a period of 14 days of treatment showed no sig-
niﬁcant differences in levels TP, ALB, GLB, TB, DB, ALP,
ALT, AST, TC, LDL-C, HDL-C, urea, CRE, LDH and K
(Table 4) (P > 0.05). The differences observed in levels of IDB,
VLDL-C, and TAG though signiﬁcant were not dose-dependent.
Na+ concentration was markedly lower in animals treated with
DRE dose of 1000 mg/kg (P = 0.030).
3.5. Photomicrograph of liver cells
Histopathological examination of the liver conﬁrmed no
cellular damage in all the treated groups, compared to control
group. Intact liver tissue with plates of hepatocytes, sinusoids
that conﬂuence with the central vein was observed. No obvious
proliferation of Kupffer cells to remove debris nor other forms of
toxicity were observed (Figure 1A–D). Results shown are for
males, similar results were obtained for females.
3.6. Photomicrograph of the kidney
Histopathological examinations of the kidneys showed no
signiﬁcant changes in the kidney in extract-treated groupsSpleen Lungs Stomach
.040 0.506 ± 0.040 1.230 ± 0.050 6.890 ± 0.610
.050 0.538 ± 0.030 1.210 ± 0.030 6.670 ± 0.430
.030 0.506 ± 0.040 1.250 ± 0.034 6.690 ± 0.260
.030 0.640 ± 0.120 1.240 ± 0.040 6.750 ± 0.330
Table 3
Hematological indices in rats orally treated with DRE.
Parameters Hematological values P value
Control 100 mg/kg 300 mg/kg 1000 mg/kg
RBC (M/mL) 7.86 ± 0.18 8.05 ± 0.18 7.54 ± 0.16 7.79 ± 0.16 0.235
HGB (g/dL) 14.88 ± 0.25 15.04 ± 0.30 14.49 ± 0.30 14.54 ± 0.19 0.389
HCT (%) 46.70 ± 0.83 47.80 ± 0.97 45.64 ± 1.10 45.43 ± 0.88 0.287
MCH (pg) 18.95 ± 0.23 18.66 ± 0.14 19.23 ± 0.13 17.83 ± 0.98 0.265
MCV (fL) 59.46 ± 0.62 59.41 ± 0.40 60.33 ± 0.30 59.31 ± 0.57 0.055
MCHC (g/dL) 31.86 ± 0.11 31.50 ± 0.13 31.76 ± 0.20 32.05 ± 0.24c 0.143
RDW-SD (fL) 29.16 ± 0.46 29.55 ± 0.25 30.16 ± 0.36 29.64 ± 0.50 0.379
Platelets × 102 (K/mL) 9.74 ± 75.95 9.98 ± 56.70 8.59 ± 108.58 9.02 ± 52.87 0.564
MPV (%) 6.99 ± 0.09 7.03 ± 0.09 7.05 ± 0.12 6.88 ± 0.11 0.650
PDW (fL) 8.29 ± 0.14 8.19 ± 0.11 8.38 ± 0.14 7.99 ± 0.16 0.243
WBC counts (K/mL) 11.93 ± 1.22 11.79 ± 0.99 9.35 ± 0.38 16.05 ± 1.12abc 0.001
Lymphocytes (%) 75.33 ± 3.03 74.55 ± 4.58 72.55 ± 3.01 68.44 ± 2.81 0.501
MID (%) 7.04 ± 0.64 6.41 ± 0.64 7.08 ± 0.33 8.34 ± 0.45 0.098
Neutrophils (%) 17.71 ± 2.45 14.14 ± 1.19 20.04 ± 2.68 23.23 ± 2.42 0.054
Values are mean ± SEM, (n = 8); a: Signiﬁcant difference between 1000 mg/kg body weight and control; b: Signiﬁcant difference between 1000 mg/kg
body weight and 100 mg/kg body weight; c: Signiﬁcant difference between 1000 mg/kg body weight and 300 mg/kg body weight; PCV: Pack cell
volume; MCV: Mean corpuscular volume; MCH: Mean corpuscular; MCHC: Mean corpuscular HGB concentration; RDW-SD: Red cell distribution
width-standard deviation; MPV: Mean platelet volume; PDW: Platelet distribution width.
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Bowman's capsule with capsular space, proximal and distal
convoluted tubules with simple cuboidal epithelium, blood
vessel were seen. There were no obvious signs of damage to
nephrons.
3.7. Photomicrograph of the spleen
Histopathological examinations of the spleen tissues showed
no signiﬁcant changes in spleen (Figure 3A–D). Normal splenic
tissue with white pulp of lymphoid cells, surrounding anTable 4
Serum biochemistry parameters in rats orally treated with DRE.
Parameters Biochemical val
Control 100 mg/kg
AST (IU/L) 166.48 ± 6.06 157.39 ± 4.17
ALT (IU/L) 49.00 ± 2.56 47.88 ± 3.30
ALP (IU/L) 513.88 ± 82.79 483.25 ± 71.07
TP (g/L) 133.12 ± 6.63 140.82 ± 7.98
ALB (g/L) 32.36 ± 0.60 31.71 ± 1.39
GLB (g/L) 100.76 ± 6.34 109.11 ± 8.10
A/G 0.33 ± 0.02 0.30 ± 0.03
DB (mmol/L) 2.60 ± 0.40 1.96 ± 0.33
IDB (mmol/L) 1.01 ± 0.23 2.07 ± 0.72
TB (mmol/L) 3.62 ± 0.44 4.04 ± 0.92
CRE (mmol/L) 21.70 ± 2.01 22.42 ± 1.48
UREA (mmol/L) 10.64 ± 0.36 10.91 ± 0.88
K (mEq/L) 5.84 ± 0.47 4.57 ± 0.34
Na+ (mmol/L) 166.27 ± 16.55 114.17 ± 13.91
LDH (IU/L) 1313.1 ± 128.73 1539.5 ± 186.77
TAG (mmol/L) 1.48 ± 0.07 1.12 ± 0.06
TC (mmol/L) 4.07 ± 0.26 3.28 ± 0.39
LDL-C (mmol/L) 3.07 ± 0.27 2.28 ± 0.33
HDL-C (mmol/L) 0.32 ± 0.01 0.50 ± 0.16
VLDL-C (mmol/L) 0.29 ± 0.01 0.22 ± 0.01
Values are mean ± SEM (n = 8); a: Signiﬁcant difference between 1000 mg/k
body weight and 100 mg/kg body weight.arteriole was observed. Surrounding the white pulp is the red
pulp traversed by venous sinuses, which indicated the absence of
no sign of damage or toxicity.
3.8. Photomicrograph of the stomach
There were no salient pathological changes in the stomach
tissues of extract-treated animals as compared to controls
(Figure 4A–D). Intact simple columnar epithelium and blood
vessel in submucosa and smooth muscle were seen. Ulceration
of the epithelia was not evident.ues at indicated dosages P value
300 mg/kg 1000 mg/kg
159.92 ± 5.10 158.96 ± 7.78 0.716
53.50 ± 1.86 56.13 ± 3.07 0.142
521.75 ± 41.38 589.25 ± 36.59 0.663
136.15 ± 4.44 143.57 ± 9.95 0.764
33.27 ± 1.75 31.22 ± 2.53 0.849
102.88 ± 4.10 112.35 ± 10.02 0.672
0.33 ± 0.02 0.30 ± 0.04 0.786
2.13 ± 0.40 2.17 ± 0.28 0.631
0.67 ± 0.22 2.86 ± 0.79 0.038
2.80 ± 0.33 5.02 ± 0.84 0.162
25.92 ± 1.50 21.02 ± 1.54 0.166
9.91 ± 0.38 10.85 ± 0.68 0.650
5.43 ± 0.68 5.30 ± 0.74 0.488
117.89 ± 19.47 101.38 ± 9.65a 0.030
1832.1 ± 163.88 1916.7 ± 160.53 0.050
1.53 ± 0.13 1.81 ± 0.14b 0.045
3.31 ± 0.20 3.56 ± 0.32 0.247
2.30 ± 0.16 2.40 ± 0.24 0.123
0.31 ± 0.03 0.33 ± 0.05 0.428
0.30 ± 0.02 0.36 ± 0.02b 0.002
g body weight and control; b: Signiﬁcant difference between 1000 mg/kg
Figure 3. Micrographs of the splenic tissues for control (A), 100 mg/kg
(B), 300 mg/kg (C), 1000 mg/kg (D) groups at the end of treatment period
of 14 days with DRE.
Figure 4. Micrographs of the stomach tissues for control (A), 100 mg/kg
(B), 300 mg/kg (C), 1000 mg/kg (D) groups at the end of treatment period
of 14 days with DRE.
Figure 1. Micrographs of the liver tissues for control (A), 100 mg/kg (B),
300 mg/kg (C), 1000 mg/kg (D) groups at the end of treatment period of 14
days with DRE.
Figure 2. Micrographs of the kidney tissues for control (A), 100 mg/kg
(B), 300 mg/kg (C), 1000 mg/kg (D) groups at the end of treatment period
of 14 days with DRE.
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In any pharmacological studies, proof of safety is necessary.
No potential drug is used clinically without its toxicity and
clinical trial studies data. Toxicological studies assist in deciding
whether a new drug should be adopted for clinical use or not.
Toxicity studies done in appropriate animal models are generally
used to assess the potential health risk of drug to humans [17].
Such data provide information on health hazards likely to arise
from a repeated exposure of the test substance to mammals, as
is being used repeatedly for the management of several
diseases. Depending on the duration of exposure of animals to
drug agents, toxicological studies may be put into four
categories; acute, sub-acute, sub-chronic and chronic studies.
In the present study, acute and sub-acute toxicity proﬁle of
the extract of the whole plant of D. rotundifolia was evaluated in
both sexes of adult SD rats. Animals were subjected to admin-
istration of DRE orally. This mode of administration was
considered the most suitable because it is the intended clinical
route of DRE administration in humans and has been used in
previous non-clinical studies.
The absence of deaths in the acute toxicity study, places the
LD50 above 5000 mg/kg. According to Oslon et al. [18], a
substance that shows LD50 at 1000 mg/kg body weight is
considered safe or of low toxicity. Implicitly, DRE could be
said to be of low toxicity. Organ and body weight are indices
that are often used in toxicological evaluations may be altered
in tumors, hyperplasias and other disease states although
deﬁnite genotoxicity is mostly required to evaluate
carcinogenic potentials of drug agents. The results in this
study show that organ and body weight indices of liver, heart,
kidney, spleen and stomach were not signiﬁcantly altered by
the 14-day extract treatment regimes. This may give an indica-
tion of the potential harmless effect of the extract to these in-
ternal organs.
This study also did not reveal any overt adverse effects on
hematological parameters in the DRE-treated animals. Hema-
tological changes such as anemia are often accompanied with
bone marrow toxicity among other causes [19]. Hematological
parameters are usually associated with health status and are of
diagnostic importance in clinical assessment of the state of
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indicators of physiological, pathological and nutritional status.
Changes in these parameters have implications on therapeutic
drug testing and toxicological factors in animals [19]. The
hematological data shows that DRE has no signiﬁcant adverse
effect on blood. This may suggest that DRE neither altered the
incorporation of hemoglobin into RBCs nor the morphology
and osmotic fragility of RBCs. HCT is a measure of the
volume of blood consisting of solid cells. The HCT which
was unaffected by the extract in all the treatment groups
indicates that the volume of RBC in the blood remained
constant. Although WBC count was elevated at the highest
DRE dose level (1000 mg/kg body weight), the normal
neutrophils would suggest that the extract may not have
induced an inﬂammatory process since these cells are usually
elevated in the course of inﬂammation [20].
A predominance of unconjugated bilirubin is suggestive of
hemolytic jaundice, whereas a preponderance of conjugated
bilirubin is generally associated with hepatic disease and extra-
hepatic biliary obstruction [21]. The changes in IDB may be of
no consequence as ALT, ALP and AST levels were not
signiﬁcantly affected. Elevated levels of AST and ALT are
often diagnostic of underlying cellular injuries [22]. This is
further supported by the normal levels of the bile pigments
observed in this study suggesting lack of adverse DRE effects
on the liver. There was also no change in the levels of urea in
this study, suggesting that kidneys were not adversely
affected. It is also interesting to note that the plant extract did
not cause any impairment on the cardiovascular system as
shown by the insigniﬁcant changes in the levels of electrolyte
and lipid proﬁle indices.
In order to conﬁrm the absence of damage in the internal
organs, histopathological assessment was done as shown in
Figures 1–4. Histopathological evaluation showed no sign of
tissue alteration or damage, thus the extract did not cause any
toxic effect on the liver, kidney, stomach and spleen over the 14-
day administration.
In conclusion, the study demonstrates that DRE is safe up to
a dose of 1000 mg/kg body weight within a 14-day period.
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